House Energy & Commerce Subcommittee Issues Testimony From Mark Cuban Cost Plus Drug CEO Oshmyansky
May 17, 2023
May 17, 2023
WASHINGTON, May 17 -- The House Energy and Commerce Subcommittee on Oversight and Investigations issued the following testimony by Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Co., involving a hearing on May 11, 2023, entitled "Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains":
* * *
At the time of writing, there are approximately 200 drug products listed as in shortage on the US FDA drug shortage database. Many . . .
* * *
At the time of writing, there are approximately 200 drug products listed as in shortage on the US FDA drug shortage database. Many . . .